reglab/housing_qa huggingface dataset:
CO Code § 12-280-124 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-124. Labeling - Rules

  A prescription drug dispensed pursuant to an order must be labeled as follows:   Drugs compounded and dispensed pursuant to a chart order for a patient in a hospital must bear a label containing the name of the outlet, the name and location of the patient, the identification of the drug, and, when applicable, any suitable control numbers, the expiration date, any warnings, and any precautionary statements.    The symptom or purpose for which the drug is being prescribed must appear on the label, if, after being advised by the practitioner, the patient or the patient's authorized representative so requests. If the practitioner does not provide the symptom or purpose for which a drug is being prescribed, the pharmacist may fill the prescription order without contacting the practitioner, patient, or patient's representative.       Except as otherwise required by law, any drug dispensed pursuant to a prescription order must bear a label prepared and placed on or securely attached to the medicine container stating at least the name and address of the prescription drug outlet, the serial number and the date of the prescription or of its dispensing, the name of the drug dispensed unless otherwise requested by the practitioner, the name of the practitioner, the name of the patient, and, if stated in the prescription, the directions for use and cautionary statements, if any, contained in the prescription.    The board shall promulgate rules concerning the labeling requirements for a prescription drug that is dispensed to a patient for outpatient use and contains an opioid, except for an opioid prescribed for treatment of a substance use disorder or that is a partial opioid antagonist, which rules must include a warning to indicate risks such as overdose and addiction.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1469, § 1, effective October 1; (3) added,(SB 19-228), ch. 276, p. 2610, § 17, effective October 1. L. 2021: (1)(b) amended,(SB 21-094), ch. 314, p. 1933, § 13, effective September 1.    Editor's note:    This section is similar to former § 12-42.5-121 as it existed prior to 2019.    Before its relocation in 2019, this section was amended in SB 19-228. Those amendments were superseded by the repeal and reenactment of this title 12, effective October 1, 2019. For those amendments to the former section in effect from May 23, 2019, to October 1, 2019, see SB 19-228, chapter 276, Session Laws of Colorado 2019.
CO Code § 12-280-125.3 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-125.3. Pharmacists' Authority - Minor Prescription Adaptions

  Except as provided in subsection (3) of this section, a pharmacist who is acting in good faith and is using professional judgment and exercising reasonable care may make the following minor adaptions to an order if the pharmacist has the informed consent of the patient for whom the prescription was provided:   A change in the prescribed dosage form or directions for use of the prescription drug if the change achieves the intent of the prescribing practitioner;    A change in the prescribed quantity of the prescription drug if the prescribed quantity is not a package size commercially available from the manufacturer;    An extension of the quantity of a maintenance drug for the limited quantity necessary to achieve medication refill synchronization for the patient; and    Completion of missing information on the order if there is sufficient evidence to support the change.       A pharmacist who adapts an order in accordance with subsection (1) of this section shall document the adaption and the justification for the change in the patient's pharmacy record with the original prescription and shall notify the prescribing practitioner of the adaption.    A pharmacist shall not adapt an order if the prescribing practitioner has written “do not adapt” on the prescription or has otherwise communicated to the pharmacist that the prescription must not be adapted.     History. Source: L. 2021: Entire section added, (SB 21-094), ch. 314, p. 1934, § 15, effective September 1.
CO Code § 12-280-125.5 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-125.5. Pharmacists' Authority to Dispense Chronic Maintenance Drugs - Rules - Liability

  In accordance with board rules adopted under subsection (2) of this section, on and after January 1, 2020, a pharmacist may dispense an emergency supply of a chronic maintenance drug to a patient without a current, valid prescription if:   The pharmacist makes every reasonable attempt but is unable to obtain authorization to refill the prescription from the prescribing health-care provider or another health-care provider responsible for the patient's care;      The pharmacist has a record of a prescription at the pharmacy or has been presented proof of a recent prescription for the chronic maintenance drug in the name of the patient who is requesting the emergency supply; or (b) (I) The pharmacist has a record of a prescription at the pharmacy or has been presented proof of a recent prescription for the chronic maintenance drug in the name of the patient who is requesting the emergency supply; or    In the pharmacist's professional judgment, the refusal to dispense an emergency supply of the chronic maintenance drug will endanger the patient's health or disrupt essential drug therapy for a chronic condition of the patient;       The amount of the chronic maintenance drug dispensed does not exceed the amount of the most recent prescription or the standard quantity or unit of use package of the drug;    The pharmacist has not dispensed an emergency supply of the chronic maintenance drug to the same patient in the previous twelve-month period; and    The prescriber of the drug has not indicated that no emergency refills are authorized.       The board shall adopt rules, in consultation with the Colorado medical board created in section 12-240-105 and the state board of nursing created in section 12-255-105, to establish standard procedures for pharmacists to follow in dispensing chronic maintenance drugs pursuant to this section. The rules adopted under this subsection (2) must include documentation requirements for a pharmacist to complete when dispensing a chronic maintenance drug without a current prescription.    A pharmacist, the pharmacist's employer, and the original prescriber of the drug are not civilly liable for an act or omission in connection with the dispensing of a chronic maintenance drug pursuant to this section unless the act or omission constitutes negligence, recklessness, or willful or wanton misconduct.      History. Source: L. 2019: Entire section added,(HB 19-1077), ch. 40, p. 138, § 6, effective October 1.    Editor's note:   This section is similar to § 12-42.5-122.5 as added in HB 19-1077. That section was superseded by the repeal and reenactment of this title 12, effective October 1, 2019. For the former section in effect from March 21, 2019, to October 1, 2019, see HB 19-1077, chapter 40, Session Laws of Colorado 2019.
CO Code § 12-280-128 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-128. Judicial Review

 Section 12-20-408 governs judicial review of all final actions and orders of the board that are subject to judicial review.   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1478, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-125 as it existed prior to 2019.
CO Code § 12-280-130 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-130. Unauthorized Practice - Penalties

  Any person who practices or offers or attempts to practice pharmacy without an active license issued under this article 280 is subject to penalties pursuant to section 12-20-407 (1)(a).    Any person who practices or offers or attempts to practice as a pharmacy technician without an active certification issued under this article 280 is subject to penalties pursuant to section 12-20-407 (1)(a).     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1479, § 1, effective October 1; entire section amended,(HB 19-1242), ch. 434, p. 3756, § 14, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-127 as it existed prior to 2019.
CO Code § 12-280-131 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-131. New Drugs - When Sales Permissible

  No person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under appropriate federal law.    This section does not apply to a drug intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of drugs if the drug is plainly labeled to be for investigational use only.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1479, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-128 as it existed prior to 2019.
CO Code § 12-280-132 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-132. Advertising of Prescription Drug Prices

 A prescription drug outlet may advertise its prices for prescription drugs. If the drug is advertised by its brand or proprietary name, the prescription drug outlet shall also include its generic name in the advertisement.   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1480, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-129 as it existed prior to 2019.
CO Code § 12-280-133 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-133. Nonresident Prescription Drug Outlet - Registration

  Any prescription drug outlet located outside this state that ships, mails, or delivers, in any manner, drugs or devices into this state is a nonresident prescription drug outlet and shall register with the board and disclose to the board the following:   The location, names, and titles of all principal entity officers and all pharmacists who are dispensing drugs or devices to the residents of this state. The nonresident prescription drug outlet shall submit a report containing this information to the board on an annual basis and within thirty days after any change of office, officer, or pharmacist.    A verification that it complies with all lawful directions and requests for information from the regulatory or licensing agency of the state in which it is licensed as well as with all requests for information made by the board pursuant to this section. The nonresident prescription drug outlet shall maintain at all times a valid, unexpired license, permit, or registration to conduct the prescription drug outlet in compliance with the laws of the state in which it is a resident. As a prerequisite to registering with the board, the nonresident prescription drug outlet shall submit a copy of the most recent inspection report resulting from an inspection conducted by the regulatory or licensing agency of the state in which it is located.       The registration requirements of this section apply only to a nonresident prescription drug outlet that only ships, mails, or delivers, in any manner, drugs and devices into this state pursuant to a prescription order.    A nonresident prescription drug outlet doing business in this state that has not obtained a registration shall not conduct the business of selling or distributing drugs in this state without first registering as a nonresident prescription drug outlet. A nonresident prescription drug outlet shall make application for a nonresident prescription drug outlet registration on a form furnished by the board. The board may require the information it deems necessary to carry out the purpose of this section.      The board may deny, revoke, or suspend a nonresident prescription drug outlet registration for failure to comply with this section or with any rule promulgated by the board.    The board may deny, revoke, or suspend a nonresident prescription drug outlet registration if the nonresident prescription drug outlet's license or registration has been revoked or not renewed for noncompliance with the laws of the state in which it is a resident.         History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1480, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-130 as it existed prior to 2019.
CO Code § 12-280-133.5 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-133.5. Nonresident 503b Outsourcing Facility - Registration - Requirements - Denial, Revocation, or Suspension - Rules

  A nonresident 503B outsourcing facility shall not conduct the business of distributing compounded prescription drugs in this state without first registering with the board as a nonresident 503B outsourcing facility. A nonresident 503B outsourcing facility shall apply for a nonresident 503B outsourcing facility registration on a form furnished by the board and shall submit the following to the board with the application:   Proof that the facility is actively registered with the FDA as a 503B outsourcing facility and is actively licensed, permitted, or registered in the state in which it is a resident;    The location, names, and titles of all principal entity officers and the name of the pharmacist in charge of the operations of the facility;    Verification that the facility complies with all lawful directions and requests for information from the FDA and from the regulatory or licensing agency of the state in which it is licensed, permitted, or registered, as well as with all requests for information made by the board pursuant to this section;    A copy of the most recent inspection report resulting from an inspection conducted by the FDA; and    Any other information the board deems necessary to carry out the purpose of this section.       A nonresident 503B outsourcing facility shall:   Maintain at all times a valid, unexpired license, permit, or registration to operate the 503B outsourcing facility in compliance with the laws of the state in which it is a resident; and    Comply with the requirements of the “Federal Food, Drug, and Cosmetic Act”, 21 U.S.C. sec. 301 et seq., as amended, or the DQSA or with FDA regulations implementing either act.       The board may deny, revoke, or suspend a nonresident 503B outsourcing facility registration if:   The facility fails to comply with this section or with any rule promulgated by the board;    The FDA has revoked or refused to renew the nonresident 503B outsourcing facility's FDA registration for failing to comply with the requirements of the “Federal Food, Drug, and Cosmetic Act”, 21 U.S.C. sec. 301 et seq., as amended, the DQSA, or FDA regulations implementing either act or the facility's FDA registration has expired or is no longer active; or    The state in which the nonresident 503B outsourcing facility resides has revoked or refused to renew the facility's license, permit, or registration for failing to comply with the laws of that state or the facility's license, permit, or registration in another state has expired or is no longer active.       The board may adopt rules as necessary to implement this section.     History. Source: L. 2021: Entire section added, (SB 21-094), ch. 314, p. 1935, § 18, effective September 1.
CO Code § 12-280-133.7 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-133.7. Third-Party Logistics Providers - Registration - Denial, Revocation, or Suspension - Rules

  A third-party logistics provider shall not conduct business in this state without first registering with the board as a third-party logistics provider. A third-party logistics provider shall apply for a registration on a form furnished by the board and shall submit the information required pursuant to rules adopted by the board. The board shall specify, by rule, the information a third-party logistics provider must submit with its application for a registration.    A third-party logistics provider shall comply with all lawful directions and requests for information from the FDA, the regulatory or licensing agency of the state in which it is licensed, permitted, or registered, and the board.    The board may deny, revoke, or suspend a third-party logistics provider registration if:   The third-party logistics provider fails to comply with this section or with any rule promulgated by the board;    The FDA has revoked or refused to renew the third-party logistics provider's FDA registration for failing to comply with the requirements of the “Federal Food, Drug, and Cosmetic Act”, 21 U.S.C. sec. 301 et seq., as amended, or the DQSA or with FDA regulations implementing either act; or    The state in which the third-party logistics provider resides has revoked or refused to renew the provider's license, permit, or registration for failing to comply with the laws of that state.       The board may adopt rules as necessary to implement this section.     History. Source: L. 2021: Entire section added, (SB 21-094), ch. 314, p. 1937, § 18, effective September 1.
CO Code § 12-280-136 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-136. Confidential Agreement to Limit Practice

  Except as specified in subsection (2) of this section, section 12-30-108 concerning confidential agreements to limit practice applies to this article 280.    This section and section 12-30-108 do not apply to a pharmacist, pharmacy technician, or intern subject to discipline for prohibited activities as described in section 12-280-126 (1)(e).     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1484, § 1, effective October 1; (2) amended,(HB 19-1242), ch. 434, p. 3756, § 15, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-134 as it existed prior to 2019.
CO Code § 12-280-137 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-137. Investigations of Suspicious Drugs

 All prescription drug outlets, manufacturers, repackagers, and wholesalers shall investigate any suspect product, as defined in the DQSA and any federal regulations implementing the DQSA, and shall use documentation and reporting procedures relating to the investigation in accordance with the DQSA and any federal regulations implementing the DQSA.   History. Source: L. 2021: Entire section added, (SB 21-094), ch. 314, p. 1937, § 20, effective September 1.
CO Code § 12-280-138 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 1 - General Provisions|§ 12-280-138. Patient Counseling - Pharmacists Required to Perform - Patient May Decline - Rules

     Except in the circumstances described in subsection (2) of this section, a pharmacist shall provide patient counseling on new medication therapy and, based on the pharmacist's professional judgment and due diligence, may provide patient counseling for any other prescription. If the pharmacist is unable to provide patient counseling orally due to language barriers, the pharmacist may use alternate means to provide the patient counseling.      Except as provided in subsection (1)(b)(II) of this section, all in-state pharmacies must ensure that their pharmacists provide patient counseling in accordance with this section. (b) (I) Except as provided in subsection (1)(b)(II) of this section, all in-state pharmacies must ensure that their pharmacists provide patient counseling in accordance with this section.    This subsection (1)(b) does not apply to an other outlet.          A patient may decline patient counseling offered by a pharmacist. A pharmacist shall document, in the form and manner specified in board rules, when a patient declines patient counseling.    The board shall adopt rules specifying:   The alternate means by which pharmacists may provide patient counseling when language barriers preclude providing patient counseling orally; and    The form and manner for pharmacists to document when a patient declines counseling, which rules must specify a documentation process that is simple and allows the documentation to be completed electronically.       This section does not apply to pharmacists who dispense prescription drugs to persons in the custody of the department of corrections.      History. Source: L. 2021: Entire section added, (SB 21-094), ch. 314, p. 1938, § 20, effective September 1.
CO Code § 12-280-201 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 2 - Pharmacy Peer Health Assistance Diversion Program|§ 12-280-201. Legislative Declaration

  The general assembly finds, determines, and declares that the creation of a pharmacy peer health assistance program for those persons subject to the jurisdiction of the board will serve to safeguard the life, health, property, and public welfare of the people of this state. A pharmacy peer health assistance program will help practitioners experiencing impaired practice due to psychiatric, psychological, or emotional problems; excessive alcohol or drug use; or alcohol or substance use disorders. The general assembly further declares that a pharmacy peer health assistance program will protect the privacy and welfare of those persons who provide services and at the same time assist the board in carrying out its duties and responsibilities to ensure that only qualified persons are allowed to engage in providing those services that are under the jurisdiction of the board.    It is the intent of the general assembly that the pharmacy peer health assistance program and its related procedures be utilized by the board in conjunction with, or as an alternative to, the use of disciplinary proceedings by the board, which proceedings are by their nature time-consuming and costly to the people of this state. The pharmacy peer health assistance program is hereby established to alleviate the need for disciplinary proceedings, while at the same time providing safeguards that protect the public health, safety, and welfare. The general assembly further declares that it intends that the board will act to implement the provisions of this article 280.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1485, § 1, effective October 1. L. 2021: Entire section amended,(SB 21-094), ch. 314, p. 1938, § 21, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-201 as it existed prior to 2019.